NASDAQ: RNAAtrium Therapeutics Inc Stock Ownership - Who owns Atrium Therapeutics?
Insider buying vs selling
Have Atrium Therapeutics Inc insiders been buying or selling?
No trades
There has been no insiders buying vs selling in the past 12 months.
Be the first to know when RNA insiders and whales buy or sell their stock.
RNA Shareholders
What type of owners hold Atrium Therapeutics Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Price T Rowe Associates Inc | 9.08% | 1,553,210 | $21.20M | Institution |
| Blackrock Inc | 7.05% | 1,205,291 | $16.45M | Institution |
| Ra Capital Management LP | 5.05% | 864,102 | $11.79M | Institution |
| Vanguard Capital Management LLC | 3.66% | 626,869 | $8.56M | Institution |
| Tig Advisors LLC | 3.55% | 607,552 | $8.29M | Institution |
| Pentwater Capital Management LP | 3.52% | 602,649 | $8.23M | Institution |
| Oconnor Alternative Investments LLC | 3.38% | 578,011 | $7.89M | Institution |
| Sessa Capital IM LP | 3.22% | 551,391 | $7.53M | Institution |
| Goldman Sachs Group Inc 1 | 2.05% | 349,950 | $4.78M | Institution |
| Farallon Capital Management LLC | 2.04% | 349,360 | $4.77M | Institution |
RNA vs Biotech Stocks
Atrium Therapeutics Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.